Skip to Content

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit https://cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at https://www.opm.gov.

Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.
Authors: Gao X,  Bashirova A,  Iversen AK,  Phair J,  Goedert JJ,  Buchbinder S,  Hoots K,  Vlahov D,  Altfeld M,  O'Brien SJ,  Carrington M
Journal: Nat Med
Date: 2005 Dec
Branches: IIB
PubMed ID: 16288280
PMC ID: not available
Abstract: An effective acquired immune response to infectious agents mediated by HLA-restricted T-cell recognition can target different stages of disease pathogenesis. We show here that three distinct HLA alleles known to alter the overall rate of AIDS progression act during distinct intervals after HIV-1 infection. The discrete timing of HLA allele influence suggests alternative functional mechanisms in immune defense against this dynamic and chronic immunosuppressive disease.